Individualised short-term therapy for adolescents impaired by attention-deficit/hyperactivity disorder despite previous routine care treatment (ESCAadol)-Study protocol of a randomised controlled trial within the consortium ESCAlife.

Julia M GeisslerThomas JansTobias BanaschewskiKatja BeckerTobias RennerDaniel BrandeisManfred DöpfnerChristina DoseChristopher HautmannMartin HoltmannCarolin JenknerSabina MillenetMarcel Romanos

Published in: Trials (2018)

German Clinical Trials Register (DRKS), Current Controlled Trial DRKS00008974, http://apps.who.int/trialsearch/Trial2.aspx?TrialID=DRKS00008974 ; http://www.drks.de/drks_web/navigate.do?navigationId=trial.HTML&TRIAL_ID=DRKS00008974 ; Registered on 28 December 2015.

Keyphrases

study protocol
clinical trial
attention deficit hyperactivity disorder
phase iii
phase ii
randomized controlled trial
open label
autism spectrum disorder
double blind
healthcare
young adults
palliative care
physical activity
quality improvement
working memory
clinical practice
chronic pain
affordable care act